Allarity Therapeutics, Inc. Earnings Per Share (Basic)
Allarity Therapeutics, Inc. (ALLR) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Allarity Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- Allarity Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.17.
- Allarity Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.21.
- Allarity Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.19.
- Allarity Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$0.78.
- Allarity Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$15.65.
- Allarity Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$6031.31.
- Allarity Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$3093.42.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-14 | -$0.39 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$0.17 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.78 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.57 10-Q · filed 2025-11-14 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.15 10-Q · filed 2026-08-14 | -$0.38 10-Q · filed 2026-08-14 | -$1.21 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$0.25 10-Q · filed 2026-05-15 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$3.93 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$5.47 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$1.72 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$6.64 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$9.96 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$15.65 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$7.71 10-Q · filed 2025-11-14 | -$13.32 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$25.33 10-Q · filed 2025-11-14 | -$37.18 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||||
| 2024-06-30 | -$3.34 10-Q · filed 2025-08-15 | -$0.11 10-Q · filed 2024-08-05 | -$21.78 10-Q · filed 2025-08-15 | -$0.73 10-Q · filed 2024-08-05 | -$42.45 derived: net income ÷ weighted average shares · filed 2025-08-15 | -$99.02 derived: net income ÷ weighted average shares · filed 2025-08-15 | ||
| 2024-03-31 | -$664.16 10-Q · filed 2025-05-09 | -$22.14 10-Q · filed 2024-05-14 | -$769.45 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$1790.75 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$2245.16 derived: net income ÷ weighted average shares · filed 2025-05-09 | |||
| 2023-12-31 | -$197.50 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1132.67 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1626.57 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$6031.31 10-K · filed 2025-03-31 | -$10.26 10-K · filed 2024-03-08 | |||
| 2023-09-30 | -$1346.09 10-Q · filed 2024-11-14 | -$2.24 10-Q · filed 2023-11-14 | -$1348.63 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$11630.75 10-Q · filed 2024-11-14 | -$19.38 10-Q · filed 2023-11-14 | -$2831.29 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$525.53 10-Q · filed 2024-08-05 | -$26.28 10-Q · filed 2023-08-14 | -$1336.40 10-Q · filed 2024-08-05 | -$66.82 10-Q · filed 2023-08-14 | -$1827.36 derived: net income ÷ weighted average shares · filed 2024-08-05 | -$2711.57 derived: net income ÷ weighted average shares · filed 2024-08-05 | ||
| 2023-03-31 | -$6356.06 10-Q · filed 2024-05-14 | -$4.43 10-Q · filed 2023-05-11 | -$1605.07 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2593.62 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$579.55 derived: net income ÷ weighted average shares · filed 2024-05-14 | |||
| 2022-12-31 | -$412.55 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$1333.83 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$361.73 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$3093.42 10-K · filed 2024-03-08 | -$2.21 10-K · filed 2023-03-13 | |||
| 2022-09-30 | -$934.29 10-Q · filed 2023-11-14 | -$0.68 10-Q · filed 2022-11-14 | -$206.68 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$2733.21 10-Q · filed 2023-11-14 | -$1.98 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | -$53.90 10-Q · filed 2023-08-14 | -$0.72 10-Q · filed 2022-10-07 | -$97.63 10-Q · filed 2023-08-14 | -$1.30 10-Q · filed 2022-10-07 | ||||
| 2022-03-31 | -$19.64 10-Q · filed 2023-05-11 | -$0.56 10-Q · filed 2022-05-27 | ||||||
| 2021-12-31 | -$4.19 10-K · filed 2023-03-13 | |||||||
| 2021-09-30 | -$0.17 10-Q · filed 2022-11-14 | -$1.06 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.70 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$1.08 10-Q · filed 2022-10-07 | -$1.78 10-Q · filed 2022-10-07 | ||||||
| 2021-03-31 | -$0.68 10-Q · filed 2022-05-27 | |||||||
| 2020-12-31 | -$2.03 10-K · filed 2022-05-17 | |||||||
| 2020-09-30 | -$0.40 10-Q/A · filed 2022-05-17 | -$1.64 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |